Equities research analysts predict that CVS Health Corp (NYSE:CVS) will report $1.70 earnings per share for the current fiscal quarter, Zacks reports. Twenty Four analysts have issued estimates for CVS Health’s earnings. The highest EPS estimate is $1.87 and the lowest is $1.68. CVS Health posted earnings of $1.69 per share during the same quarter last year, which suggests a positive year-over-year growth rate of 0.6%. The company is expected to announce its next earnings report before the market opens on Wednesday, August 7th.

On average, analysts expect that CVS Health will report full-year earnings of $6.84 per share for the current year, with EPS estimates ranging from $6.76 to $6.99. For the next financial year, analysts forecast that the company will report earnings of $7.11 per share, with EPS estimates ranging from $6.90 to $7.40. Zacks Investment Research’s EPS averages are an average based on a survey of research firms that that provide coverage for CVS Health.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, May 1st. The pharmacy operator reported $1.62 EPS for the quarter, beating the consensus estimate of $1.50 by $0.12. CVS Health had a positive return on equity of 16.80% and a negative net margin of 0.08%. The company had revenue of $61.65 billion for the quarter, compared to analyst estimates of $60.39 billion. During the same period last year, the company earned $1.48 earnings per share. CVS Health’s quarterly revenue was up 34.8% compared to the same quarter last year.

CVS has been the topic of a number of research analyst reports. CIBC reaffirmed a “market perform” rating on shares of CVS Health in a research note on Monday, April 15th. Raymond James reaffirmed an “average” rating and issued a $10.50 price target on shares of Hudbay Minerals in a research note on Thursday, April 18th. ValuEngine lowered Zumiez from a “hold” rating to a “sell” rating in a research note on Tuesday, July 2nd. Barclays set a $325.00 price target on Align Technology and gave the stock a “buy” rating in a research note on Thursday, April 11th. Finally, Citigroup lowered BCE from a “buy” rating to a “neutral” rating in a research note on Thursday, May 2nd. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating, sixteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $76.48.

A number of institutional investors have recently made changes to their positions in CVS. Bay Harbor Wealth Management LLC raised its position in CVS Health by 1,871.4% in the first quarter. Bay Harbor Wealth Management LLC now owns 552 shares of the pharmacy operator’s stock valued at $30,000 after purchasing an additional 524 shares during the period. Centaurus Financial Inc. raised its position in CVS Health by 570.8% in the first quarter. Centaurus Financial Inc. now owns 1,630 shares of the pharmacy operator’s stock valued at $30,000 after purchasing an additional 1,387 shares during the period. Manchester Financial Inc. purchased a new stake in CVS Health in the second quarter valued at $31,000. C J Advisory Inc purchased a new stake in CVS Health in the first quarter valued at $33,000. Finally, Murphy Pohlad Asset Management LLC purchased a new stake in CVS Health in the fourth quarter valued at $39,000. Hedge funds and other institutional investors own 77.33% of the company’s stock.

Shares of NYSE:CVS traded up $0.10 during trading on Tuesday, reaching $55.54. The stock had a trading volume of 4,745,702 shares, compared to its average volume of 7,085,939. The company has a current ratio of 0.95, a quick ratio of 0.64 and a debt-to-equity ratio of 1.45. The stock has a fifty day moving average of $55.11. The company has a market cap of $72.15 billion, a PE ratio of 7.84, a PEG ratio of 1.25 and a beta of 0.88. CVS Health has a 1-year low of $51.72 and a 1-year high of $82.15.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 2nd. Investors of record on Thursday, July 25th will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Wednesday, July 24th. This represents a $2.00 dividend on an annualized basis and a yield of 3.60%. CVS Health’s payout ratio is 28.25%.

CVS Health Company Profile

CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.

See Also: Accumulation/Distribution

Get a free copy of the Zacks research report on CVS Health (CVS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.